AdaptHealth Q1 net loss $2.1M, revenue up 6.4% to $792.5M, adj. EBITDA up 18.3%

AdaptHealth Corp.

2024-Q1 EPS reported -$0.02 revenue$792,497,000

Net revenue $792.5M (+6.4% YoY); net loss $2.1M vs net income $15.7M prior year.
Adjusted EBITDA $158.5M (+18.3%), margin 20.0%.
Operating cash flow $49.0M, down from $140.2M due to Change Healthcare breach; free cash flow ($38.9M).
Non-acquired revenue growth 6.2%; leverage expected below 3x in 2024.
Chairman/Interim CEO Richard Barasch stepping away; Suzanne Foster to assume leadership.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

AdaptHealth Corp. reported first quarter ended March 31, 2024 results: revenue $792.5 million, net income $2.1 million. Guidance reaffirmed.

Period: first quarter ended March 31, 2024
Revenue: $792.5 million
Net income: $2.1 million
Guidance: reaffirmed
Result: reported results

Exact text from the filing

Net revenue was $792.5 million compared to $744.6 million, an increase of 6.4%. • Net loss attributable to AdaptHealth Corp. was $2.1 million compared to net income of $15.7 million.

View on SEC.gov

708 earnings releases filed in the last 30 days. Browse all earnings releases →

AdaptHealth Corp. filing history →

Source: SEC EDGAR

accession 0001628280-24-020835

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.